本研究旨在进行一项可行性试验，检视进行随机对照试验的可行性与可接受性，该试验评估体重管理干预对人体测量指标（体重及 BMI）、饮食质素、体能活动水平、身体及心理社会功能、减重自我效能及生活质量的影响。
适应症：Cancer、Weight Loss、Overweight and Obesity
入组条件
纳入标准
- Chinese cancer survivors attending the one-off face-to-face survivorship care clinic
- who are Cantonese- or Mandarin- speaking
- aged 18 or above
- diagnosed with early-stage disease (stage 0-II)
- have completed primary and adjuvant treatments such as chemotherapy and radiotherapy
- and with a BMI ≥ 23 kg/m2, as indicative as overweight or obesity using Asia-Pacific BMI cutoffs at 3-months reassessment
排除标准
- Non-Chinese survivors with advanced or metastatic disease
- who have communication difficulties, mobility impairment or cognitive disabilities
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。